Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Dendrobium officinale polysaccharides may help with hair growth, skin moisturization, and protection against oxidative damage.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

White hair grows thicker and faster than black hair due to higher activity of growth-related genes and proteins.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Type I interferons play a key role in the development of various skin diseases.

STAT5 activation is crucial for starting the hair growth phase.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.